Hemodialysis Concentrates Market Scope
Hemodialysis concentrates are intended for the hemodialysis treatment. It is mixed with purified water to generate a dialysate solution, employed during hemodialysis treatment. Dialysis fluid is prepared according to the individual patientís needs to help regulate their electrolyte and acid-base balance and remove metabolic waste products. There are two types of hemodialysis concentrates are used such as Bicarbonate and acidic. They are available in powder and solution form. The increasing kidney-related disease across the globe driving the demand for the hemodialysis concentrates. In 2017, 746,557 Americans had kidney failure, and needed dialysis or a kidney transplant to survive. Nearly 500,000 of these patients received dialysis at least 3 times per week to replace kidney function. Nearly 125,000 people started ESKD treatment in 2017, of which 120,834 started dialysis, and 20,945 received a kidney transplant.
The Hemodialysis Concentrates market study is segmented by Type (Acid Concentrates and Bicarbonate Concentrates), by Application (Dialysis Center and Home) and major geographies with country level break-up.
Research Analyst at AMA estimates that United States and German Players will contribute to the maximum growth of Global Hemodialysis Concentrates market throughout the predicted period.
Baxter International (United States), B. Braun (Germany), Rockwell Medical (United States), Fresenius Medical Care (Germany), Nipro (Japan), MEDIVATORS (United States), Dialysis Medical Solutions (United States), Unipharm JSC (United States), Renacon Pharma (Pakistan), Surni Group (India), Weigao Group (China), BIOLIGHT (China), Dialife SA (Switzerland) and Haemo Pharma GmbH (Austria) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are NxStage Medical (United States), Serumwerk Bernburg AG (Germany), Cantel Medical Division (United States), CMS (Canada), Global Meditronic (India), Advin Health Care (India) and SUNSHINE SOLUTION (India).
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a
preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
AdvanceMarketAnalytics has segmented the market of Global Hemodialysis Concentrates market by Type, Application and Region.
On the basis of geography, the market of Hemodialysis Concentrates has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Leaders and their expansionary development strategies
The market is highly competitive due to the presence of several leading vendors within the market. These prominent vendors are adopting some organic and inorganic strategies such as mergers, acquisitions, product launches, among others in order to gain competitive advantage. Moreover, the prominent vendors are also focusing on technological advancements in order to cater to the products as per the market necessities.
On 8 June 2020, The Nipro Group from Japan, has through its subsidiary Nipro Medical Europe NV acquired MTN Neubrandenburg GmbH, a global manufacturer of dialysis concentrate based in Weitin. This acquisition is expected to expand the hemodialysis concentrates offerings in the global markets.
- Rapid Technological Advancements in Hemodialysis Concentrates
- The Rising Kidney Related Diseases across the Globe
- Negligible Preference of Patients for Kidney Transplantation
- Increasing Prevalence of Diabetes and Hypertension
- Increase in Investment for the Development of New Products and Reimbursement from Governments for the Treatment of Kidney Diseases
- Increasing Number of Dialysis Centers
- Growing Preference for Home Hemodialysis (HHD) Treatment
- Lower Awareness of Kidney Diseases Treatment Modalities
- Stringent Regulatory Policies for the Approval and Manufacturing of Dialysis Products
- Sustainability of Small and Medium-Sized Companies in the Highly Competitive Market
Key Target AudienceHemodialysis Concentrates Manufacturers, Hemodialysis Concentrates Raw Material Suppliers, Hemodialysis Concentrates Traders/Distributors, Regulatory & Government Bodies, End Users, Downstream & Upstream Vendors, Research & Consulting Firms and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase